ustekinumab biosimilars on Humana Basic Rx Plan (S5884-116)
Wezlana, Selarsdi, Pyzchiva and others
Covered, with prior authorization required.
Tier 5 (specialty tier). Quantity limit of 1.5 per 84 days.
$983.82
Patient pays / month, after deductible
$1,445.07
Patient pays / month, before the $615.00 deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
USTEKINUMAB 45 mg/.5mL Injection, Solution at a preferred retail pharmacy, from the plan's negotiated price of $3,935.27 for a month. Other covered strengths are listed below.
Prior authRequired on all 3 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 3 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| USTEKINUMAB 45 mg/.5mL Injection, Solution | 5 | $983.82 | PA · 1.5 per 84 days |
| USTEKINUMAB 45 mg/.5mL Injection, Solution | 5 | $1,212.25 | PA · 1.5 per 84 days |
| USTEKINUMAB 90 mg/mL Injection, Solution | 5 | $1,821.89 | PA · 3 per 84 days |
Other IL-17 and IL-23 biologics on this plan
Verify with the plan before prescribing or filling. Member services: (800)281-6918. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5884-116